GILD,Gilead Sciences, Inc. | Healthcare

Healthcare

GILD

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Gilead Sciences, Inc.GILD

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis.

It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections.

Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases.

The company was incorporated in 1987 and is headquartered in Foster City, California.

Latest News >

Government to introduce e-invoice system under GST, says report

May 28, 2019

In the initial phase, the service will only be available to large companies which will register every transaction on the GST network.

Government needs to focus on labour, capital for GDP growth of 7.5%, says HSBC

May 28, 2019

India's growth potential could rise to 7.5 percent from the current 7 percent if the government allows its recent reforms such as goods and services tax, Insolvency and Bankruptcy Code and digital payment push to get more traction, said Pranjul Bhandari, chief India economist, HSBC.

Money, money, money: behind the scenes at a euro note printing press

May 28, 2019

In secretive vaults in Rome, crisp 100 and 200 euro banknotes are rolling off the printing press. The new notes with enhanced security features will offer better protection against forgeries, officials told Reuters, which was given rare access to see the Bank of Italy's Banknote Printing Department at work. The notes, named after the mythological princess Europa and released on Tuesday, have large value numerals in a bolder design and contrasting shades to make them easier to identify, European Central Bank (ECB) Banknotes Director Ton Roos said. "If you hold the banknote up to the light and then on the left hand side you see the watermark with the portrait of ... Europa and on the right hand side, on the top of the silver stripe, you have a portrait window, also with the portrait of Europa," Roos said as he held up a new 100 euro note. "When you look to the (bottom left) corner, you have a numeral that is green ... when you tilt the note ... you see a light line going up and down and inside the numeral you see little euro logos," he said. The printing of the 100 and 200 euro notes completes the Europa series that has been gradually replacing the first set of euro notes first issued in 2002.

MHA issues lookout notice against promoters of DHFL

May 28, 2019

Ministry of Home Affairs has issued lookout notice against promoters of DHFL in connection with allegations of financial fraud by promoters of the company.